Purinergic receptor regulation of LPS-induced signaling and pathophysiology

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Macrophages are key immune cells activated by lipopolysaccharide (LPS) to release inflammatory mediators.
• Exogenous nucleotide receptors, specifically P2X and P2Y purinergic receptors, modulate macrophage responses to LPS.
• Elevated P2Y1, P2Y2, and P2X7 mRNA in LPS-stimulated cells suggests their involvement in LPS-induced pathophysiology.

Purpose of the Study:

• To investigate the role of purinergic receptors in modulating lipopolysaccharide (LPS)-induced responses in vivo.
• To determine the capacity of various adenine nucleotides to affect LPS-induced mortality in mice.
• To elucidate the combined contribution of P2Y and P2X7 receptors in controlling LPS effects.

Main Methods:

• Utilized in vivo mouse models to assess LPS-induced mortality.
• Administered various adenine nucleotides, including P2X7-specific and broad-spectrum ligands, to evaluate their protective effects.
• Measured inflammatory mediator production and cellular signaling pathways (NF-kappaB, ERK-1/2) in response to LPS and purinergic receptor modulation.

Main Results:

• BzATP, a P2X7-directed ligand, did not prevent LPS-induced death.
• 2-MeS-ATP and 2-Cl-ATP, which target multiple P2X and P2Y receptors, demonstrated protective effects against LPS-induced mortality.
• Inhibition of P2X7 with oxidized-ATP blocked LPS-induced nitric oxide production and signaling pathway activation in macrophages.

Conclusions:

• The coordinated action of P2Y and P2X7 receptors is crucial for regulating LPS responses in vivo.
• Targeting both P2Y and P2X7 receptor classes may represent a promising therapeutic strategy for LPS-induced conditions.
• Understanding the interplay between purinergic receptors and LPS signaling is vital for developing novel immunomodulatory treatments.